146 related articles for article (PubMed ID: 38520919)
1. Modeling hypoxia-induced radiation resistance and the impact of radiation sources.
Possenti L; Vitullo P; Cicchetti A; Zunino P; Rancati T
Comput Biol Med; 2024 May; 173():108334. PubMed ID: 38520919
[TBL] [Abstract][Full Text] [Related]
2. Carbon ion radiotherapy: impact of tumor differentiation on local control in experimental prostate carcinomas.
Glowa C; Peschke P; Brons S; Neels OC; Kopka K; Debus J; Karger CP
Radiat Oncol; 2017 Nov; 12(1):174. PubMed ID: 29121984
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in light ion radiation therapy.
Brahme A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
[TBL] [Abstract][Full Text] [Related]
4. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A
Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602
[TBL] [Abstract][Full Text] [Related]
5. Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.
Wozny AS; Lauret A; Battiston-Montagne P; Guy JB; Beuve M; Cunha M; Saintigny Y; Blond E; Magne N; Lalle P; Ardail D; Alphonse G; Rodriguez-Lafrasse C
Br J Cancer; 2017 May; 116(10):1340-1349. PubMed ID: 28407653
[TBL] [Abstract][Full Text] [Related]
6. Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?
Auberger T; Thürriegl B; Freude T; Weissfloch L; Senekowitsch-Schmidke R; Kneschaurek P; Wagner FM; Molls M
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():52-6. PubMed ID: 10394398
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic and extrinsic tumor characteristics are of minor relevance for the efficacy of split-dose carbon ion irradiation in three experimental prostate tumors.
Glowa C; Peschke P; Brons S; Debus J; Karger CP
Radiother Oncol; 2019 Apr; 133():120-124. PubMed ID: 30935567
[TBL] [Abstract][Full Text] [Related]
8. DNA damage response of clinical carbon ion versus photon radiation in human glioblastoma cells.
Lopez Perez R; Nicolay NH; Wolf JC; Frister M; Schmezer P; Weber KJ; Huber PE
Radiother Oncol; 2019 Apr; 133():77-86. PubMed ID: 30935585
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.
Ramaekers BL; Pijls-Johannesma M; Joore MA; van den Ende P; Langendijk JA; Lambin P; Kessels AG; Grutters JP
Cancer Treat Rev; 2011 May; 37(3):185-201. PubMed ID: 20817407
[TBL] [Abstract][Full Text] [Related]
10. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
Oelfke U; Bortfeld T
Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
[TBL] [Abstract][Full Text] [Related]
11. Impact of Single Dose Photons and Carbon Ions on Perfusion and Vascular Permeability: A Dynamic Contrast-Enhanced MRI Pilot Study in the Anaplastic Rat Prostate Tumor R3327-AT1.
Bendinger AL; Seyler L; Saager M; Debus C; Peschke P; Komljenovic D; Debus J; Peter J; Floca RO; Karger CP; Glowa C
Radiat Res; 2020 Jan; 193(1):34-45. PubMed ID: 31697210
[TBL] [Abstract][Full Text] [Related]
12. COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.
Taylor RE
Br J Radiol; 2008 Mar; 81(963):169-71. PubMed ID: 18208851
[TBL] [Abstract][Full Text] [Related]
13. Basics of particle therapy II biologic and dosimetric aspects of clinical hadron therapy.
Rong Y; Welsh J
Am J Clin Oncol; 2010 Dec; 33(6):646-9. PubMed ID: 20395789
[TBL] [Abstract][Full Text] [Related]
14. Secondary radiation measurements for particle therapy applications: prompt photons produced by
Mattei I; Bini F; Collamati F; De Lucia E; Frallicciardi PM; Iarocci E; Mancini-Terracciano C; Marafini M; Muraro S; Paramatti R; Patera V; Piersanti L; Pinci D; Rucinski A; Russomando A; Sarti A; Sciubba A; Solfaroli Camillocci E; Toppi M; Traini G; Voena C; Battistoni G
Phys Med Biol; 2017 Feb; 62(4):1438-1455. PubMed ID: 28114112
[TBL] [Abstract][Full Text] [Related]
15. [Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions].
Combs SE; Schulz-Ertner D; Herfarth KK; Krempien R; Debus J
Chirurg; 2006 Dec; 77(12):1126-32. PubMed ID: 17119885
[TBL] [Abstract][Full Text] [Related]
16. Late effects from hadron therapy.
Blakely EA; Chang PY
Radiother Oncol; 2004 Dec; 73 Suppl 2():S134-40. PubMed ID: 15971329
[TBL] [Abstract][Full Text] [Related]
17. Organ-confined prostate carcinoma radiation brachytherapy compared with external either photon- or hadron-beam radiation therapy. Just a short up-to-date.
Alberti C
Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):769-74. PubMed ID: 21780545
[TBL] [Abstract][Full Text] [Related]
18. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
20. Treatment planning intercomparison for spinal chordomas using intensity-modulated photon radiation therapy (IMRT) and carbon ions.
Schulz-Ertner D; Nikoghosyan A; Didinger B; Karger CP; Jäkel O; Wannenmacher M; Debus J
Phys Med Biol; 2003 Aug; 48(16):2617-31. PubMed ID: 12974578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
